The February 2013 Issue of The Burrill Report - 02/01/2013

SCOTUS Weighs Pay-for-Delay
Podcast: April 1, 2013 Read More
The April 2013 Issue of
The Burrill Report
Read More
RARE Webinar: Understanding Drug Development
Opportunities for Rare Disease Patients and Advocates to Speed Development of New Therapies. Read More
Will Regulation Dampen Digital Health Innovation
Podcast: March 25, 2013 Read More
Spanish Researchers Identify Key Mutation in CLL
New discovery has broad implications for cancers characterized by telomere abnormalities. Read More
AstraZeneca Slashes R&D;, Sales Jobs in Consolidation
Global headquarters will move from London to Cambridge Read More
Sanofi and Biogen get EU Nod on MS Drugs
European regulator recommends approval for oral therapies. Read More
Affymax Eliminates 75 Percent of Staff, Considers Sale or Bankruptcy
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More
Two Life Sciences IPOs Debut
Tetraphase Pharmaceuticals and Enanta, both infectious disease companies, complete offerings. Read More
President Obama Outlines $2B Energy Security Trust
Blueprint to “shift our cars and trucks off oil for good.” Read More

[Please login to post comments]